-
Utkarsh Small Finance Bank
Reasonable IPO pricing makes it attractive among peers though pre-issue bloom in profit may advise caution.
-
Nexus Select Trust REIT
Asset quality exudes optimism for long term though immediate distribution yield is projected to be lower than listed peers.
-
Mankind Pharma
Will it break the jinx of IPOs priced above 1000 times the face value?
-
Bikaji Foods
Ultra-high P/E multiple for a depleting profit margin? Boom-time IPO pricing is bound to give bitter taste during market downturn!
-
LIC
Embedded Value makes the offer attractive but, as private insurers gain market share, what happened to GIC and NIA can happen to LIC sooner or later